Results
|
|
2001.
|
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. [electronic resource] by
- O'Sullivan, J M
- McCready, V R
- Flux, G
- Norman, A R
- Buffa, F M
- Chittenden, S
- Guy, M
- Pomeroy, K
- Cook, G
- Gadd, J
- Treleaven, J
- Al-Deen, A
- Horwich, A
- Huddart, R A
- Dearnaley, D P
Producer: 20020802
In:
British journal of cancer vol. 86
Availability: No items available.
|
|
|
2002.
|
|
|
|
2003.
|
Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology. [electronic resource] by
- Giglio, J
- Rey, A
- Cerecetto, H
- Pirmettis, I
- Papadopoulos, M
- León, E
- Monge, A
- López de Ceráin, A
- Azqueta, A
- González, M
- Fernández, M
- Paolino, A
- León, A
Producer: 20070126
In:
European journal of medicinal chemistry vol. 41
Availability: No items available.
|
|
|
2004.
|
|
|
|
2005.
|
Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. [electronic resource] by
- Dadachova, Ekaterina
- Moadel, Tiffany
- Schweitzer, Andrew D
- Bryan, Ruth A
- Zhang, Tong
- Mints, Lisa
- Revskaya, Ekaterina
- Huang, Xianchuan
- Ortiz, Geraldina
- Nosanchuk, Jerome S
- Nosanchuk, Joshua D
- Casadevall, Arturo
Producer: 20060718
In:
Cancer biotherapy & radiopharmaceuticals vol. 21
Availability: No items available.
|
|
|
2006.
|
|
|
|
2007.
|
|
|
|
2008.
|
|
|
|
2009.
|
|
|
|
2010.
|
|
|
|
2011.
|
|
|
|
2012.
|
|
|
|
2013.
|
|
|
|
2014.
|
|
|
|
2015.
|
|
|
|
2016.
|
|
|
|
2017.
|
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study. [electronic resource] by
- Ringhoffer, Mark
- Blumstein, Norbert
- Neumaier, Bernd
- Glatting, Gerhard
- von Harsdorf, Stephanie
- Buchmann, Inga
- Wiesneth, Markus
- Kotzerke, Jörg
- Zenz, Thorsten
- Buck, Andreas K
- Schauwecker, Peter
- Stilgenbauer, Stephan
- Döhner, Hartmut
- Reske, Sven N
- Bunjes, Donald
Producer: 20050922
In:
British journal of haematology vol. 130
Availability: No items available.
|
|
|
2018.
|
|
|
|
2019.
|
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities. [electronic resource] by
- Buchmann, Inga
- Bunjes, Donald
- Kotzerke, Jörg
- Martin, Hans
- Glatting, Gerhard
- Seitz, Ulrike
- Rattat, Dirk
- Buck, Andreas
- Döhner, Hartmut
- Reske, Sven N
Producer: 20021209
In:
Cancer biotherapy & radiopharmaceuticals vol. 17
Availability: No items available.
|
|
|
2020.
|
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein. [electronic resource] by
- Forero-Torres, Andres
- Shen, Sui
- Breitz, Hazel
- Sims, Robert B
- Axworthy, Don B
- Khazaeli, M B
- Chen, Kuang-Ho
- Percent, Ivor
- Besh, Stephen
- LoBuglio, Albert F
- Meredith, Ruby F
Producer: 20051024
In:
Cancer biotherapy & radiopharmaceuticals vol. 20
Availability: No items available.
|